Part Details | CIPROFLOXACIN ORAL
6505-01-492-8089
Alternate Parts: NDC50419077701, NDC50419-0777-01, NDC50419077701, NDC50419-0777-01, 010682, 01-0682, NDC00085177701, NDC00085-1777-01, CIPRO, 6505-01-492-8089, 01-492-8089, 6505014928089, 014928089
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-492-8089
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC50419-0777-01 | 07HH4 | BAYER HEALTHCARE LLCDBA BAYER HEALTHCARE-VITERION |
| NDC50419-0777-01 | 13521 | BAYER PHARMACEUTICALS CORPORATION |
| 01-0682 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| NDC00085-1777-01 | 1F095 | SCHERING-PLOUGH CORPORATION |
| CIPRO | 1F095 | SCHERING-PLOUGH CORPORATION |
Technical Data | NSN 6505-01-492-8089
| Characteristic | Specifications |
|---|---|
| SPECIAL FEATURES | CIPROFLOXACIN MICROENCAPSULATED; 250 MG PER 5 ML, 100 ML AFTER RECONSTITUTION, ORAL SUSPENSION; THE DRUG IS COMPOSED OF TWO COMPONENTS (MICROCAPSULES AND DILUENT); STORE BELOW 25 DEGREES C (77 DEGREES F) PROTECT FROM FREEZING |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CIPROFLOXACIN SUSPENSION 250MG/5ML 100ML AFTER RECONSTITUTION |